Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Cancer Institute Clinical Trials and Translational Research
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting. The meeting will also be videocast and can be
accessed from the NIH Videocasting and Podcasting Web site (http://videocast.nih.gov/).
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee.
Date: November 4, 2015.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: Strategic Discussion of NCI's Clinical and Translational
Place: National Institutes of Health, Building 31, C-Wing, 6th
Floor, Room 10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Sheila A. Prindiville, MD, MPH, Director,
Coordinating Center for Clinical Trials, National Institutes of
Health, National Cancer Institute, 9609 Medical Center Drive, Room
6W136, Rockville, MD 20850, 240-276-6173, email@example.com.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
Information is also available on the Institute's/Center's home
page: http://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an
agenda and any additional information for the meeting will be posted